(Q49050940)

18 February 2018

title

Abeta amyloidosis induces the initial stage of tau accumulation in APP(Sw) mice (English)

1 reference

18 February 2018

author name string

Y Tomidokoro

1

1 reference

18 February 2018

K Ishiguro

2

1 reference

18 February 2018

Y Harigaya

3

1 reference

18 February 2018

E Matsubara

4

1 reference

18 February 2018

M Ikeda

5

1 reference

18 February 2018

J M Park

6

1 reference

18 February 2018

K Yasutake

7

1 reference

18 February 2018

T Kawarabayashi

8

1 reference

18 February 2018

K Okamoto

9

1 reference

18 February 2018

M Shoji

10

1 reference

18 February 2018

language of work or name

English

0 references

publication date

1 February 2001

1 reference

18 February 2018

number of pages

4

1 reference

inferred from page(s)

published in

Neuroscience Letters

1 reference

18 February 2018

volume

299

1 reference

18 February 2018

issue

3

1 reference

18 February 2018

page(s)

169-172

1 reference

18 February 2018

A sequence of cytoskeleton changes related to the formation of neurofibrillary tangles and neuropil threads

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2800%2901767-5

7 January 2021

Modified amyloid beta protein ending at 42 or 40 with different solubility accumulates in the brain of Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2800%2901767-5

7 January 2021

Correlative Memory Deficits, Abeta Elevation, and Amyloid Plaques in Transgenic Mice

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2800%2901767-5

7 January 2021

Possible role of tau protein kinases in pathogenesis of Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2800%2901767-5

7 January 2021

Analysis of phosphorylation of tau with antibodies specific for phosphorylation sites

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2800%2901767-5

7 January 2021

Phosphorylated tau in human cerebrospinal fluid is a diagnostic marker for Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2800%2901767-5

7 January 2021

Diffusible, nonfibrillar ligands derived from Abeta1-42 are potent central nervous system neurotoxins

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2800%2901767-5

7 January 2021

Insulin transiently increases tau phosphorylation: involvement of glycogen synthase kinase-3beta and Fyn tyrosine kinase

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2800%2901767-5

7 January 2021

Distribution of active glycogen synthase kinase 3beta (GSK-3beta) in brains staged for Alzheimer disease neurofibrillary changes

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2800%2901767-5

7 January 2021

Secreted amyloid beta-protein similar to that in the senile plaques of Alzheimer's disease is increased in vivo by the presenilin 1 and 2 and APP mutations linked to familial Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2800%2901767-5

7 January 2021

Two amyloid precursor protein transgenic mouse models with Alzheimer disease-like pathology

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2800%2901767-5

7 January 2021

Precursor of cdk5 activator, the 23 kDa subunit of tau protein kinase II: its sequence and developmental change in brain

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2800%2901767-5

7 January 2021

Preferential labeling of Alzheimer neurofibrillary tangles with antisera for tau protein kinase (TPK) I/glycogen synthase kinase-3 beta and cyclin-dependent kinase 5, a component of TPK II.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2800%2901767-5

7 January 2021

10.1016/S0304-3940(00)01767-5

Identifiers

DOI

1 reference

18 February 2018

1 reference

18 February 2018